Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/11/2003US6645500 Method for down-regulating osteoprotegerin ligand activity
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645482 Sulfated proteoglycan; one or more of a hexosamine sulfate,a flavone, olive kernel extract, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of CRH, caffeine, and a polyamine.
11/11/2003US6645481 Polyethylene glycol, in an amount sufficient to induce a controlled bowel movement within 12 to 24 hours
11/11/2003US6645476 Preparable by free-radical copolymerization of macromonomers containing an end-group capable of polymerization, a hydrophilic moiety based on polyalkylene oxides, and a hydrophobic moiety with olefincally unsaturated comonomers
11/11/2003US6645470 Treatment and system for nicotine withdrawal
11/11/2003US6645469 Method for dispensing S-adenosyl-methionine in a micro fine powdered form by inhalation
11/11/2003US6645468 Medicinal aerosol formulation
11/11/2003US6645466 Dry powder for inhalation
11/11/2003US6645168 Decreasing postoperative analgesic opiate requirement; reducing operating site time for patient
11/11/2003US6644320 Treatment of hepatitis C using hyperthermia
11/11/2003CA2292497C Dietary compositions for enhancing metabolism and alleviating oxidative stress
11/11/2003CA2290332C Optically pure androgen mediator
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/11/2003CA2264745C Method of inhibiting biosynthesis of eif5a
11/11/2003CA2264569C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
11/11/2003CA2262086C Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
11/11/2003CA2259594C Subunit respiratory syncytial virus vaccine preparation
11/11/2003CA2144967C Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/11/2003CA2143756C N-cyano-n'-pyridylguanidines as serotonin antagonists
11/11/2003CA2113424C Muscarinic agonists
11/11/2003CA2091440C 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as alpha adrenergic agents
11/11/2003CA2055637C Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
11/09/2003CA2385774A1 Composition to reduce food cravings and supress the appetite
11/08/2003CA2419122A1 Wildlife nutritional supplement
11/06/2003WO2003091694A2 Method for assay of cognition and memory based on low frequency stimulation
11/06/2003WO2003091675A2 Ultrasonic doppler effect speed measurement
11/06/2003WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003WO2003091433A1 EXPRESSION SYSTEMS FOR STEM LOOP RNA MOLECULE HAVING RNAi EFFECT
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091403A2 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/06/2003WO2003091391A2 Atherosclerotic phenotype determinative genes and methods for using the same
11/06/2003WO2003091290A1 Method for reduction of residual organic solvent in carbomer
11/06/2003WO2003091272A1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations
11/06/2003WO2003091269A1 A gene abnormally expressed in autoimmune diseases and malignancies
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091256A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME
11/06/2003WO2003091253A1 Nitrosated imidazopyridines
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091250A1 [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents
11/06/2003WO2003091249A1 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091246A1 Pyrrole derivatives as inhibitors of erk2 and uses thereof
11/06/2003WO2003091245A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism
11/06/2003WO2003091244A1 New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
11/06/2003WO2003091243A1 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics
11/06/2003WO2003091242A1 Novel thiol derivative, process for producing the same and use thereof
11/06/2003WO2003091241A1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists
11/06/2003WO2003091239A1 Estrogen receptor modulators
11/06/2003WO2003091237A1 Process for producing proanthocyanidine-rich material
11/06/2003WO2003091236A1 Imidazolinylmethyl aralkylsulfonamides
11/06/2003WO2003091234A1 Biguanide derivative and therapeutic agent for diabetes containing the same
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091231A1 Pna monomer and precursor
11/06/2003WO2003091229A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
11/06/2003WO2003091226A1 Triazole derivatives as tachykinin receptor antagonists
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091224A1 Quinazoline derivative and medicine
11/06/2003WO2003091223A1 Pyrimidine derivative
11/06/2003WO2003091219A1 Isoquinoline derivatives
11/06/2003WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
11/06/2003WO2003091213A1 Novel amide derivatives or salts thereof
11/06/2003WO2003091212A1 Cinnamic acid amides
11/06/2003WO2003091211A1 Novel heteroaryl compounds
11/06/2003WO2003091207A2 Method of preparing amine stereoisomers
11/06/2003WO2003091205A1 Sulfamidophenylalkylamines and their production and use
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003091201A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity
11/06/2003WO2003091199A1 Method for chlorinating tertiary alcohols
11/06/2003WO2003091194A1 Hyperforin derivatives, the use thereof and formulations containing them
11/06/2003WO2003091193A1 Hyperforin halogenated derivatives, the use thereof and formulations containing them
11/06/2003WO2003090912A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
11/06/2003WO2003090870A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
11/06/2003WO2003090869A1 Lxr modulators
11/06/2003WO2003090868A1 Method and apparatus for ultrasound treatment of connective tissue
11/06/2003WO2003090818A2 Drug-delivery endovascular stent and method for treating restenosis
11/06/2003WO2003090798A1 Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
11/06/2003WO2003090794A1 Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets
11/06/2003WO2003090793A1 Removal of adenine during a process of pathogen reducing blood and blood components
11/06/2003WO2003090785A1 Methods and conpositions for treating, preventing or delaying onset of a neoplasm
11/06/2003WO2003090784A1 Treatment of metabolic syndrome
11/06/2003WO2003090783A1 Preventive/remedy for diabetes
11/06/2003WO2003090782A1 Cell death inhibitor
11/06/2003WO2003090779A1 Remedy for lung cancer
11/06/2003WO2003090778A2 Dna vaccine combined with an inducer of tumor cell apoptosis
11/06/2003WO2003090770A1 Process for producing proanthocyanidine-rich material
11/06/2003WO2003090767A1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof
11/06/2003WO2003090765A1 Medicinal compositions containing phtocrosslinkable chitosan derivative
11/06/2003WO2003090764A1 Mineral absorption promoter
11/06/2003WO2003090763A1 Composition and kit for the treatment of inflammatory bowel diseases
11/06/2003WO2003090762A1 Long acting compositions comprising zidovudine and lamivudine
11/06/2003WO2003090760A1 Oxolide antibacterials
11/06/2003WO2003090759A1 Difructose anhydride-containing composition and use thereof
11/06/2003WO2003090758A1 Method for treating inflammatory disorders
1 ... 5282 5283 5284 5285 5286 5287 5288 5289 5290 5291 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 ... 7860